מס' | שם הבדיקה והמוטציות הנבדקות | גן | שיטת הבדיקה |
1 | Achondroplasia: c.1138G>A, c.1138G>C (p.G380R) | FGFR3 | Sequencing |
2 | Achromatopsia: c.1207C>T (p.R403X) | CNGB3 | Sequencing |
3 | Acrodermatitis enteropathica: c.1223delC (p.A408fsX481) | SLC39A4 | Sequencing |
4 | Albinism: S50X, G253R, R299H, R402X, IVS2-1G>A G47D, IVS2-7T>A | TYR | Sequencing |
5 | Alpha-1 Antitripsin Deficiency: PiZ- E342K, PiS- E264V | SERPINA1 | RFLP |
6 | Alport syndrome: 5232g>A (R1677Q) | COL4A5 | Sequencing |
7 | Alstrom: c.8088C>T (p.R2670X) | ALMS1 | Sequencing |
8 | Apparent Mineralocorticoid Excess (AME): c.793+1G>T (IVS3+1G>T | HSD11B2 | Sequencing |
9 | Ataxia Telangiectasia (AT): c.2284_2285delCT, c.497del7.5kb, c.103C>T (p.R35X) | ATM | RFLP or Elisa Kit or Allele specific PCR |
c.5558A>T (p.D1853V) | Sequencing |
10 | Autosomal Recessive Cone-Rod Dystrophy (arCRD): c.1648G>A (G550R), c.3607G>A (G1203R), c.4538insC, c.5460+1G>A, c.5882G>A (G1961E), c.3608G>A (G1203E) | ABCA4 | RFLP or Sequencing |
11 | Autosomal-Recessive Intellectual Disability and Postnatal Microcephaly: c.1423C>A | TRAPPC9 | RFLP or Sequencing |
12 | Bartter syndrome: c.212C>T (p.T71M) | KCNJ1 (ROMK) | Sequencing |
13 | Bartter and Gitelman syndrome: c.1313G>A (p.R438H) | CLCNKB | Sequencing |
14 | Biotinidase deficiency: p.G35S | BTD | Sequencing |
15 | Bloom Syndrome: 2281 del6/ins7 | BLM | RFLP or Elisa Kit |
16 | Breast & Ovarian Cancer: 185delAG, 5382insC, 3053T>g (Y978X) N363S (c.1088A>G), c.3228delAG | BRCA1 | Allele specific PCR or Elisa Kit |
6174delT, 6503delTT, 8675delAG | BRCA2 |
17 | Canavan: 693C>A, 854A>C | ASPA | RFLP or Elisa Kit |
18 | Catecholamine-Induced Polymorphic Ventricular Tachycardia: D307H | CASQ2 | RFLP |
19 | CEDNIK syndrome: c.220delG | SNAP29 | Sequencing |
20 | Central Core disease of Muscle: c.9262G>A (p.V3087M) | RYR1 | Sequencing |
21 | Cockayne syndrome: Y322X , c.843+1G>C | ERCC8 (CSA) | RFLP |
22 | Congenital Insensitivity to Pain with Anhydrous (CIPA): c.207-208delTG | NTRK1 | RFLP or Sequencing |
c.2150C>T |
23 | Congenital Muscular Dystrophy: 160C>T | FKRP | RFLP |
24 | Congenital Neutropenia: c.758G>A (R253H) | G6PC3 | Sequencing |
25 | Costeff Optic Athropy Syndrome: IVS1-1G>C | OPA3 | RFLP |
26 | Cystic Fibrosis: deltaF508, G542X, N1303K, W1282X, S549R, 3849+10kbC>T, D1152H, G85E, 405+1G>A, W1089X, T360K, 4010delTATT, R75X, 2183AA>G, 3120+1Kb del8.6Kb, 1717G>A, 5T, 2751+1insT, 3121-1G>A, Y1092X, I1234V, 1677delTA, G1244E, C225X, E92X | CFTR | NANOGEN or RFLP or Elisa Kit or Multiplex-PCR |
27 | Distal Arthrogryposis Syndrome: R174Q | TNNI2 | RFLP or Sequencing |
28 | Dystrophic Epidermolysis Bullosa: c.2767G>A (p.G923R), c.7371delC | COL7A1 | Sequencing |
29 | Factor V Leiden : 1691G>A | F5 | RFLP or Elisa Kit |
30 | Familial Dysautonomia: 2507+6T>C, R696P | IKBKAP | RFLP or Elisa Kit |
31 | Familial Exudative Vitreoretinopathy (FEVR): c.542G>T (p.C181F) | TSPAN12 | Sequencing |
32 | Familial Mediterranean Fever (FMF): V726A, M680I, M694V, M694I, E148Q, P369S | MEFV | RFLP or Elisa Kit or Sequencing |
33 | Fanconi Anemia type A: 2172/2173insG, c.4275delT | FANCA | RFLP or Elisa Kit |
34 | Fanconi Anemia type C: IVS4+4A>T | FANCC | RFLP or Elisa Kit |
35 | Fragile-X: Number of trinucleotide repeats | FMR1 | Genescan analysis |
36 | Frontoparietal Polymicrogyria: c.1796_1800delTGCGCC/insAGATCCTGTGGGCA | GRP56 | Sequencing |
37 | Galactosemia: c.152G>A (p.R51Q) | GALT | Sequencing |
38 | Gaucher Type 1: 84GG, IVS2+1, N370S, D409H, L444P, V394L | GBA | RFLP or Elisa Kit |
39 | Glycogen Storage Disease Type Ia (GSD Ia): R83C | G6PT | RFLP or Elisa Kit |
40 | Glycogen Storage Disease Type III (GSD III): 4455delT | AGL | RFLP or Sequencing |
41 | Glutaric Acidemia IIc: c.1084G>A (p.G362R) | ETFDH | Sequencing |
42 | Hereditary Non Polyposis Colon Cancer (HNPCC): c.204delG | MSH2 | Sequencing |
43 | HMG (3-hydroxy, 3-methyglutaryl) COA Lyase Deficiency: R41Q | HMGCL | RFLP |
44 | Hurler syndrome: c.1184A>C (p.T366P) | IDUA | Sequencing |
45 | Hypochondroplasia: c.1620C>A (p.N540K) | FGFR3 | Sequencing |
46 | Hypoparathyrodisim, retardation, dysmorphism: c.155-166del | TBCE | Sequencing |
47 | Hypophosphatasia: p.R450C (R433C), c.1171delC (c.1172delC) ... שם ישן c.26C>A (p.A9N) | TNSALP | RFLP or Sequencing |
48 | Hypotricosis (AR): c.280_369dup | LIPH | Sequencing or Separating on sgarose gel |
49 | Infantile Cerbral and Cerebellar Atrophy: c.1112T>C (p.L371P) | MED17 | Sequencing |
50 | Infantile Cerebellar-Retinal Degeneration: c.336C>G (p.S112R) | ACO2 | Sequencing |
51 | Janus Kinase 2 (JAK2): V617P | JAK2 | Sequencing or Allele specific |
52 | Joubert Syndrome: G1890X (שיבלי), c.164-167delCTCA | NPHP6 (CEP290) | RFLP or Sequencing |
53 | Joubert Syndrome 2: c.35G>T (p.R12L) | TMEM216 | Sequencing |
54 | Lafora epilepsy, progressive myoclonic 2A: c.108_139del | EPM2A | Sequencing or separating on agarose gel |
55 | Lebers: exon12 del 4121-4130 , c.4005+1G>A | CRB1 | RFLP or Sequencing |
Lebers: c.1495+2_1295+3insT | TULP1 |
Lebers: c.985G>T (p.G329C) | CNGA3 |
56 | Limb Girdle muscular dystrophy (LGMD2B): Ins23bp | DYSF (LGMD2B) | RELP |
57 | Limb Girdle muscular dystrophy (LGMD2C): 525delT | SGCG (LGMD2C) | PCR and Genescan |
58 | Lipoid Congenital adrenal hyperplasia: (Steroidogenic Acute Regulatory protein) R193X | STAR | RFLP |
59 | Maple Syrup Urine Disease (MSUD): R183P | BCKDHB | RFLP |
60 | Maple Syrup Urine Disease (MSUD): p.S133X | DBT | Sequencing |
61 | Meckel-gruber syndrome type 1 (MKS1): Q350X | MKS1 | Sequencing |
62 | Meckel-gruber syndrome type 2 (MKS2): c.47G>C (p.Gly16Ala) - מוטציה זו נקראת גם c.230G>C, p.Gly77Ala לפי שעתוק RNA אחר הרשום במאגר הגנטי. | TMEM216 | Sequencing |
63 | Meckel-gruber syndrome type 3 (MKS3): c.4065+1delG (IVS10+1delG) | MKS3 | Sequencing |
64 | Imprinting Mentalretardation Dysmorphism Syndrome: G236R | KNCK9 | RFLP or Sequencing |
65 | Metachromatic Leukodystrophy: Q190H p.P377L – נבדקת ביהודים ממוצא תימני. | ARSA | RFLP |
66 | Methylenetetrahydrofolate Reductase (MTHFR): | MTHFR | RFLP or Elisa Kit |
677C>T c.474A>T (p.G158G)- יהודים בוכרים. |
67 | Metochondrial Depletion Syndrome (MDS): c.542T>A (p.I181N) | TK2 | sequencing |
68 | Microcephaly, epilepsy, and diabetes syndrome: c.79delT ו- c.62T>G | IER3IP1 | sequencing |
69 | Molybdenum Cofactor Deficiency type I (MoCoD): c.971G>A (G324E) | MOCS1 | MOCS1 |
70 | Mucolipidosis IV (ML IV): del(ex1-7), IVS3-2A>G | MCOLN1 | RFLP or Elisa Kit |
71 | Myopathy recurrent myoglobinuria mitochondrial: c.1A>T (p.M1L) | FDX1L | Sequencing |
72 | Nemaline myopathy: R2478_D2512del | NEB | RFLP |
73 | Nephrogenic Diabetes Insipidus (AR): )c.298G>T (p.G100X) | AQP2 | sequencing |
74 | Nephrotic Syndrome Type 3 (NPHS3): c.4463A>G (p.R1488P) | PLCE1 | sequencing |
75 | Neuronal Ceroid Lipofuscinosis type 7 (NCL): c.472G>A (p.G158S) | MFSD8 | sequencing |
76 | Neuropathy & Striatal Necrosis: c.373G>A (p.G125S) | SLC25A19 | sequencing |
77 | Nieman-Pick Type A: L302P, delfsP330, R496L 677delT | SMPD1 | RFLP |
78 | Nieman-Pick Type C: c.2279_2281delTCT | NPC1 | Sequencing |
79 | Non syndromic deafnes- Connexin 26: 35delG, 167delT, W77R, V37I, R184P, 101delGAG, IVS1+1G>A | GJB2 | Allele specific PCR or RFLP or sequencing |
80 | Non syndromic deafnes- Connexin 30: del(DJB6-D13S1830) | GJB6 | Allele specific PCR |
81 | Non syndromic deafnes: c.1810C>T (R604X), c.1939T>C (S647P) | TMC1 | Sequencing |
82 | Nonketotic hyperglycinemia: H42R | NKH | RFLP |
83 | Nuclear receptor Co-Repressor 2: c.52C>T (p.R18C) | NCOR2 | Sequencing |
84 | Oculopharyngeal Muscular Dystrophy (OPMD): Expansion of GCG repeats | PABP2 | Genescan |
85 | Osteogenesis Imperfecta Type VII (OI7): c.793+1G>T (IVS3+1G>T) | CRTAP | Sequencing |
86 | Pelizaeus-Merzbacher-like disease (PMLD)-HSP60: D29G (g.1512A>G) | HSPD1 | Sequencing |
87 | Pendred syndrome: c.1197del T | PDS | Sequencing |
88 | Pompe disease: p.L355P, p.D404N | GAA | Sequencing |
89 | Pramyotonia congenital: c.4343G>A (R1448H) | SCN4A | Sequencing |
90 | Primary hyperoxaluria type I: 849G>C (D243H), IVS2+1G>A (480+1G>A) c.997A>T (p.R333X) | AGXT | RFLP |
91 | Progressive Cerebello-Cerebral Atrophy (PCCATR): c.715G>A (p.A239T), c.1001A>G (p.Y334C) | SepSecS | Sequencing |
92 | Progressive myoclonic epilepsy: c.108_139del | EPM2A | Sequencing |
93 | Progressive Rod-Cone Degeneration (PRCD): R22X (c.64C>T) | PRCD | RFLP |
94 | Propionic acidemia (PCCA): Exon1 del 26-37 | PCCA | Sequencing |
95 | Prothrombin (Factor II): 20210G>A | F2 | RFLP or Elisa Kit |
96 | Pseudorheumatoid Dysplasia: c.535-536delTG | WISP3 | RFLP or sequencing |
97 | Pycnodysostosis disease: X330W | CTSK | RFLP |
98 | QF-PCR בדיקת אנפלואדיות של כומוזומים: 13, 18, 21 X, Y | Chr. 13, 18, 21, X, Y | GeneScan |
99 | Refsum disease: c.959C>T (p.S320F) | PEX12 | Squencing |
100 | Renal Tubular Acidosis (RTA): IVS3-1G>A | ATP6V1B1 | Squencing |
101 | Retinitis Pigmentosa (RP): c.187+1G>T | PDE6G | Squencing |
102 | Retinitis Pigmentosa (RP): c.377C>T (p.A126V) | RDH12 | Squencing RFLP |
103 | Sandhoff disease: IVS8+5G>A(c.1082+5G>A) | HEXB | Squencing |
104 | Sequencing of known genes: | FOXC2 | Squencing |
PDS (Pendred syndrome) |
TMEM70 |
ECGF1 (MNGIE syndrome) |
SLC25A15 (HHH syndrome) |
FAM20C |
ARX |
STAR |
PTEN |
105 | Severe Combined Immune deficiency, AR (SCID): c.1361T>A (p.L454Q) | RAG1 | Squencing |
106 | Short Stature, Onychodysplasia, Facial Dysmorphism, and Hypotrichosis yndrome (SOFT): c.512T>C (p.L171P) | POC1A | Squencing |
107 | Smith-Lemli opits syndrome (SLO): 755A>G (N252S) | DHCR7 | Squencing |
108 | Spinal Muscular Atrophy (SMA): Deletion of exon 7 and 8 | SMN1 SMN2 | MALPA and GenScan |
109 | Spastic ataxia, Charlevox-Saguenay type: 7312delAG | SACS | Sequencing |
110 | Spastic paraplegia: Q40X (c.118C>T) | SPG11 (KIAA1480) | Sequencing |
c.5456delAG |
c.4339C>T (p.Q1447X) |
111 | Spastic paraplegia: c.6702_6771del | SPG15 (ZFYVE26) | RFLP or sequencing |
112 | Spondylocostal dysostosis: 593insGCGGT | DLL3 | Sequencing |
113 | Tay-Sachs: 1278insTATC, IVS12+1G>C, G269S (805G>A), IVS5-2G>A, DeltaF304/305, R170Q | HEX A | RFLP or Elisa Kit or Genescan |
114 | Thalassemia: IVS1-110, N37, Sickle cell | HBB | RFLP |
115 | Thyroid peroxidase: Exon 10: 1708C>T (R540X), Exon 9: 1567G>A (G493S) | TPO | RFLP or Sequencing |
116 | TSH Resistance (TSHR) syndrome- Hyperthyropinemia: Exon 2: P68S, Exon 10: L653V | TSHR | RFLP or Sequencing |
117 | UPD: Chr 7, 14, 15, 16 | | GeneScan |
118 | Usher syndrome type I: R245X | PCDH15 | RFLP or Elisa Kit |
119 | Usher syndrome: c.1134-1146dup | MYO7A | Sequencing |
120 | Usher syndrome 2A: c.239-240insGTAC | USH2A | Sequencing |
c.2209C>T (p.R737X) |
c.5519G>T (p.RG1840V) |
121 | Usher syndrome 3A: c.144T>G (p.N48K) | USH3A | Sequencing |
122 | Warburg Micro Sybdrom: c.2386G>A (p.E796K) | RAB3GAP1 | Sequencing |
123 | Wiskott Aldrich syndrome: G153T | WASP | RFLP |
124 | Wolfram-like syndrome, autosomal dominant: c.2590G>A (p.E864K) | WFS1 | Sequencing |